4 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 4 Phase 1, 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Stage IIIB Cervical Cancer AJCC v8: new trials by email Literature Review of Stage IIIB Cervical Cancer AJCC v8 trials Research Report on Stage IIIB Cervical Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 138 | 2022-03-31 | 2026-08-20 |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Medical Device Usage and Evaluation, Quality-of-Life Assessment, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Active not recruiting | University of Southern California | 173 | 2021-11-24 | 2026-10-05 | |
| Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer Counseling, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Stage I Cervical Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 4 | 2021-05-20 | 2024-05-09 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes Patient Monitoring, Questionnaire Administration - Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 | Completed | City of Hope Medical Center | 22 | 2020-08-11 | 2026-10-14 | |
| Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer Atezolizumab, Brachytherapy, Cisplatin - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2019-01-07 | 2025-11-12 |
| MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer Internal Radiation Therapy, Magnetic Resonance Imaging - Human Papillomavirus-Related Carcinoma, Human Papillomavirus-Related Cervical Carcinoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 26 | 2018-08-03 | 2026-09-15 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer Biospecimen Collection, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ | Not applicable | Terminated | M.D. Anderson Cancer Center | 409 | 2014-10-27 | 2025-07-14 |
| Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix Follow-Up, Medical Chart Review - Cervical Large Cell Neuroendocrine Carcinoma, Cervical Neuroendocrine Carcinoma | Recruiting | M.D. Anderson Cancer Center | 750 | 2013-05-16 | 2026-09-14 |
Uterine Cervical Neoplasms (9) · Vaginal Neoplasms (4) · Vulvar Neoplasms (3) · Carcinoma, Renal Cell (2) · Colorectal Neoplasms (2) · Ovarian Neoplasms (2) · Bone Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Lobular (1) · Carcinoma, Medullary (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Transitional Cell (1) · Carcinosarcoma (1)
Female Urogenital Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Genital Diseases (9) · Genital Diseases, Female (9) · Genital Neoplasms, Female (9) · Neoplasms by Site (9) · Urogenital Diseases (9) · Uterine Cervical Diseases (9) · Uterine Diseases (9) · Uterine Neoplasms (9) · Neoplasms (8) · Urogenital Neoplasms (8) · Vaginal Diseases (4) · Adenocarcinoma (3) · Carcinoma (3)
Brachytherapy (2) · Immunoglobulin G (2) · Magnetic Resonance Spectroscopy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Biopsy (1) · Chromatin Immunoprecipitation Sequencing (1) · Cisplatin (1) · Colony-Stimulating Factors (1) · Counseling (1) · Cyclophosphamide (1) · Disulfides (1) · Follow-Up Studies (1) · Platinum (1) · Radiation (1) · Radiosurgery (1)
M.D. Anderson Cancer Center (4) · City of Hope Medical Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Ohio State University Comprehensive Cancer Center (1) · University of Southern California (1)
United States (9)
Allison M Quick, MD (1) · Ann H Klopp (1) · Jyoti S Mayadev (1) · Kathleen Schmeler (1) · Kimberly Miller, PhD (1) · Laleh Melstrom (1) · Larissa A. Meyer (1) · Lilie L Lin (1) · Yanyan Lou, MD, PhD (1)
P30CA014089 (1), P30CA016672 (1), P30CA033572 (1), R37CA256867 (1), U10CA180868 (1)